Search clinical trials for: Asymptomatic carriers

Total 852 results

Illumina, Inc.
Helix OpCo, LLC

Completed

Evaluation of the COVIDSeq Test in Saliva Specimens From COVID-19 Asymptomatic Illumina Personnel

SARS-CoV-2

United States
ClinOne, Inc.
University of Colorado, Denver; United States Department of Defense; BioIntelliSense... and other collaborators

Completed

Wearable Diagnostic for Detection of COVID-19 Infection

COVID-19

United States
DR. MALA KHAN
Bangladesh Reference Institute of Chemical Measurements (BRICM)

Completed

Virucidal Effect of PVP-I on COVID-19 and as Well as Safety of Its Application on Nasopharynx & Oropharynx (COVID-19)

Efficacy, Self | Effect of Drug | Virus Infection, RNA

Bangladesh
Clinical Centre of Serbia

Completed

Aortic Valve Replacement Versus Conservative Treatment in Asymptomatic Severe Aortic Stenosis (AVATAR)

Aortic Stenosis

Ireland, Czechia, Lithuania, Belgium, Croatia, France, Italy, Poland, Serbia
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.

Completed

Clinical Pharmacokinetics of Mitoxantrone Hydrochloride Liposome Injection in Recurrent/Refractory Lymphoma Subjects

Recurrent/Refractory Lymphoma

China
Postgraduate Institute of Dental Sciences Rohtak

Completed

Effect of Primary Non-surgical Endodontic Therapy on Glycaemic Control in Type 2 Diabetic Patients With Asymptomatic Apical Periodontitis

Apical Periodontitis | Diabete Type 2

India
Stanford University

Terminated

Efficacy Study of Preconception Treatment of an Asymptomatic Bacterial Infection in an Infertility Population

Infertility | Vaginosis, Bacterial | Miscarriage

United States
Zagazig University

Completed

Sleeve Gastrectomy and Cholecystectomy Are Safe in Obese Patients With Asymptomatic Cholelithiasis

Bariatric Surgery Candidate
National Heart, Lung, and Blood Institute (NHLBI)

Completed

Role of p53 Gene in Metabolism Regulation in Patients With Li-Fraumeni Syndrome

Mitochondrial Disorders | Li-Fraumeni Syndrome | Carriers of p53 Mutation

United States
National Institute of Allergy and Infectious Diseases...
Protein Sciences Corporation

Completed

Active Immunization of Asymptomatic, HIV-Infected Individuals With Recombinant GP160 HIV-1 Antigen: A Phase I/II Study of Immunogenicity and Toxicity

HIV Infections

United States
National Institute of Allergy and Infectious Diseases...
Genentech, Inc.; MicroGeneSys Inc (nka Protein Sciences Corporation)

Completed

A Placebo-Controlled, Phase I Clinical Trial to Evaluate the Safety and Immunogenicity of Recombinant Envelope Proteins of HIV-1 gp160 and gp120 in Children >= 1 Month Old With Asymptomatic HIV Infection

HIV Infections

United States, Puerto Rico
National Institute of Allergy and Infectious Diseases...

Completed

A Pharmacokinetic and Tolerance Study of Oral Ganciclovir in HIV-Infected Children With Asymptomatic Cytomegalovirus Infection and Low CD4 Cell Counts or Quiescent Cytomegalovirus Disease

HIV Infections | Cytomegalovirus Infections

United States, Puerto Rico
National Institute of Allergy and Infectious Diseases...
Protein Sciences Corporation

Completed

A Phase I/II Dose Escalation Study of Intradermal gp160 to Evaluate Safety, Delayed Type Hypersensitivity (Skin Test) Responses and Immunogenicity in Asymptomatic HIV Seropositive Patients With More Than 400 CD4+ Cells

HIV Infections

United States
National Institute of Allergy and Infectious Diseases...
Bristol-Myers Squibb; Glaxo Wellcome

Completed

A Phase I/II, Open Label Study to Evaluate the Antiviral Potential of Combination Zidovudine and 2' 3'-Dideoxyinosine (Didanosine) in Patients With Asymptomatic HIV Disease

HIV Infections

United States
National Institute of Allergy and Infectious Diseases...

Completed

Safety and Efficacy of Zidovudine for Asymptomatic HIV-Infected Individuals

HIV Infections

United States
National Institute of Allergy and Infectious Diseases...

Completed

Aerosols in the Treatment of Asymptomatic Pneumocystis Pneumonia: A Pilot Study Assessing the Effectiveness of Aerosolized Pentamidine as Treatment of Subclinical Pneumocystis Infection in Patients With No Clinical Symptoms

HIV Infections | Pneumonia, Pneumocystis Carinii

United States
National Institute of Allergy and Infectious Diseases...
Immuno-US

Completed

A Phase I Multicenter Clinical Trial to Evaluate the Safety and Immunogenicity of Immuno-AG Recombinant HIV gp160 in Asymptomatic HIV Seropositive Individuals

HIV Infections

United States
National Institute of Allergy and Infectious Diseases...

Completed

A Phase I Safety and Immunogenicity Trial of HIV-1 gp120 C4-V3 Hybrid Polyvalent Peptide Immunogen Mixed in Mineral Oil Containing Mannose Mono-Oleate (IFA)

HIV Infections

United States
National Institute of Allergy and Infectious Diseases...
Glaxo Wellcome

Completed

A Phase III Study to Evaluate the Safety, Tolerance, and Efficacy of Early Treatment With Zidovudine (AZT) in Asymptomatic Infants With HIV Infection

HIV Infections

United States, Puerto Rico
Medical College of Wisconsin

Completed

Oligosaccharide for Cdiff(+) Heme-onc Patients

Hematologic Diseases | Clostridium Difficile

United States
Meshalkin Research Institute of Pathology of Circulation

Completed

The SIBERIA Trial (Acculink™ Versus CGuard™) (CAS)

Patients With Aterosclerotic Carotid Stenosis | Symptomatic Patients (Stenosis > 50%) | Asymptomatic Patients (Stenosis ≥80%)

Russian Federation
Fondazione IRCCS Istituto Nazionale dei Tumori,...
Istituto Oncologico di Bari

Completed

Dietary Intervention and BRCA Penetrance

Breast Cancer | BRCA1 Mutation | BRCA2 Mutation | Dietary Modification

Italy
Assistance Publique - Hôpitaux de Paris
Fonds IMMUNOV

Completed

Study of the Immunological and Virological Response of Patients With COVID-19 and Presenting an Asymptomatic or Pauci-symptomatic Form (AMBUCOV) (AMBUCOV)

Covid19 | SARS-CoV-2

France
Biogen

Terminated

A Study of Aducanumab in Participants With Mild Cognitive Impairment Due to Alzheimer's Disease or With Mild Alzheimer's Disease Dementia to Evaluate the Safety of Continued Dosing in Participants With Asymptomatic Amyloid-Related Imaging Abnormalities (EVOLVE)

Cognitive Dysfunction | Alzheimer's Disease

United States
Celgene

Terminated

Post-authorisation Study of Biological Relapse in Patients With Multiple Myeloma (EPA-MMBR)

Multiple Myeloma

Spain
Delphinus Medical Technologies, Inc.

Completed

Delphinus SoftVue Prospective Case Collection - ARM 2 (SV PCC ARM2)

Breast Neoplasms

United States
Delphinus Medical Technologies, Inc.

Completed

Delphinus SoftVue Prospective Case Collection - ARM 1 (SV PCC ARM1)

Breast Neoplasms

United States
Soroka University Medical Center

Active, not recruiting

Intracranial Activity of AZD9291 (TAGRISSO) in Advanced EGFRm NSCLC Patients With Asymptomatic Brain Metastases

Lung Cancer

Israel
Becton, Dickinson and Company

Withdrawn

Capturing Infectious COVID-19 Asymptomatic Cases in Singapore

Covid19 | SARS CoV-2

Singapore
Mazandaran University of Medical Sciences

Enrolling by invitation

Corticosteroid Effects on Asymptomatic Gadolinium-enhancing Lesions in Multiple Sclerosis

Multiple Sclerosis, Relapsing-Remitting | Magnetic Resonance Imaging | Methylprednisolone

Iran, Islamic Republic of
Novartis Pharmaceuticals
Amgen; Banner Alzheimer's Institute

Terminated

A Study of CNP520 Versus Placebo in Participants at Risk for the Onset of Clinical Symptoms of Alzheimer's Disease (GS2)

Alzheimers Disease

Spain, United States, Belgium, Italy, Germany, Australia, Israel, Taiwan, Japan, Canada, Korea, Republic of, United Kingdom, France, China, Argentina, Finland, Singapore, Portugal, Chile, Mexico, Switzerland, Netherlands, Iceland, Puerto... and more
University Hospital, Montpellier

Completed

Interchromosomal Insertion Carriers PGT-SR

Infertility | Interchromosomal Breakpoint

France
Rush University Medical Center

Completed

High Order Spectral Analysis of Local Field Potential Data on a Subgroup of Parkinson's Disease Patients Who Are Carriers of Mutations in the Glucocerebrosidase (GBA) Gene Undergoing DBS Electrode Placement

Parkinson Disease

United States
Sidney Kimmel Comprehensive Cancer Center at Johns...
Bayer; Dendreon

Completed

Study of Sipuleucel-T W/ or W/O Radium-223 in Men With Asymptomatic or Minimally Symptomatic Bone-MCRPC

Prostate Cancer

United States
Barcelonabeta Brain Research Center, Pasqual Maragall...
Obra Social La Caixa, Spain

Completed

Study for Cognitive and Genetic Characterization of a 45-65 Years Old Population

Healthy Individuals

Spain
University of California, Irvine

Completed

Cardiac CT's Role in Asymptomatic Patients With Diabetes and Metabolic Syndrome (CTRAD)

Diabetes | Metabolic Syndrome

United States
University of British Columbia
Roche Pharma AG; Health Canada

Enrolling by invitation

COVID-19 Rapid Testing for Self-Administration Among an Asymptomatic Sample

Covid19 | Asymptomatic Shedding Viral

Canada
Duke University
International Centre for Diarrhoeal Disease Research, Bangladesh; Ministry... and other collaborators

Completed

Dynamics of Subclinical Malaria: Preliminary Study

Malaria

Myanmar
Centre Hospitalier Intercommunal Creteil
Association Clinique Thérapeutique Infantile du val de Marne; GPIP; Francophone...

Withdrawn

Part 2 on the Study Prevalence of SARS -Cov2 Carriage in Asymptomatic and Mildly-symptomatic Children (COVILLE2) (WHO) (COVILLE2)

COVID19
University of Hawaii
Genentech, Inc.; Dendreon

Completed

Clinical Study of Atezolizumab (Anti-PD-L1) and Sipuleucel-T in Patients With Asymptomatic or Minimally Symptomatic Metastatic Castrate Resistant Prostate Cancer

Prostate Cancer Metastatic

United States
National Taiwan University Hospital

Unknown

Measuring Deep and Superficial Multifidus and the Activation Pattern During Dynamic Task Correlating With Trunk Stability Ability and Functional Performance in Different Ages Asymptomatic and Unspecific Low Back Pain Adult

Low Back Pain

Taiwan
University Hospital, Basel, Switzerland

Completed

SARS-CoV-2 /COVID-19 Admission Screening in a University Hospital Setting

Covid19 | SARS-CoV-2

Switzerland
University of Rome Tor Vergata

Completed

Efficacy and Safety of Liposomal Lactoferrin in COVID-19 Patients With Mild-to-Moderate Disease and in COVID-19 Asymptomatic Patients

Covid19

Italy
Mark Ledwidge
The Heartbeat Trust

Active, not recruiting

Personalised Prospective Comparison of ARni With ArB in Patients With Natriuretic Peptide eLEvation (PARABLE)

Hypertension | Atrial Remodeling | Cardiovascular Morbidity | Myocardial Dysfunction | Atrial Arrhythmia | Left Ventricular Remodeling | Left Ventricular Diastolic Dysfunction | Inflammatory Myopathy | Fibrosis Myocardial

Ireland
University of British Columbia
Providence Health & Services; Vancouver Airport Authority; WestJet Airlines; KLM...

Completed

An Approach to Screening for COVID-19 at Vancouver Airport

Healthy | Asymptomatic Condition

Canada
University Hospital, Basel, Switzerland
Schweizerische Herzstiftung

Active, not recruiting

Prognosis in Asymptomatic Mitral Regurgitation (PAMIR) Study

Mitral Regurgitation

Germany, Switzerland
Bradley University

Completed

Immediate Decrease of Muscle Biomechanical Stiffness Following Dry Needling in Asymptomatic Participants

Healthy

United States
Anahuac University

Completed

Prevalence of Carriers of Genetic Diseases in the Mexican Jewish Community

Genetic Predisposition | Carrier, Gestational

Mexico
U.S. Army Medical Research and Development Command
Walter Reed Army Institute of Research (WRAIR)

Completed

Merozoite Surface Protein 1 Antibody Response in Asymptomatic Human Malaria Infection

Malaria

United States
Judit Pich Martínez

Terminated

Study of Genetic Alzheimer's Disease Mutation Carriers in Preclinical Stages of the Disease 18F-Florbetaben Positron Emission Tomography Study

Alzheimer Disease

Spain

Search clinical trials for: Asymptomatic carriers

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Japan

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations